You will automatically be redirected in 10 seconds. Or, you can click the link below:

https://www.streetinsider.com/Globe+Newswire/AEON+Biopharma+Completes+Enrollment+in+Phase+2+Study+of+ABP-450+%28prabotulinumtoxinA%29+for+Preventive+Treatment+of+Chronic+Migraine/22516458.html